市場調査レポート
商品コード
1467871
血管閉鎖装置の市場レポート:製品、アクセス、手技、エンドユーザー、地域別、2024~2032年Vascular Closure Devices Market Report by Product, Access, Procedure, End-User, and Region 2024-2032 |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
血管閉鎖装置の市場レポート:製品、アクセス、手技、エンドユーザー、地域別、2024~2032年 |
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2~3営業日
|
世界の血管閉鎖装置市場規模は2023年に15億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに24億米ドルに達し、2024~2032年の間に5.1%の成長率(CAGR)を示すと予測しています。急成長する医療産業、心血管疾患の有病率の増加、患者における効果的な出血管理に対する需要の高まりは、市場を牽引する重要な要因のひとつです。
血管閉鎖装置(VCD)は、血管造影後に動脈にできた小さな穿刺を即座に塞ぐために、世界中の病院、クリニック、専門・外来手術センターで使用されています。これらの装置は、従来の機械的圧迫に比べ、大腿ルートでカテーテル治療を受ける患者の間で広く利用されています。これらの装置は、鼠径部の穿刺部位からの即時出血のリスクを軽減するのに役立ちます。これに加えて、大きな体格を設定し、抗凝固療法や抗血小板療法を行う際にも役立ちます。止血までの時間の短縮、患者の移動の促進、長期臥床に伴う患者の不快感の軽減、入院期間の短縮、大腿動脈合併症の予防など、さまざまな利点があるため、VCDの需要は世界的に増加しています。
現在、世界中で脳卒中や冠動脈疾患、末梢動脈疾患、大動脈疾患などの心血管疾患(CVD)の有病率が上昇しています。このことは、急成長する医療産業とともに、市場の成長を支える重要な要因の一つとなっています。これに加えて、CVDsの診断と治療のためのカテーテル治療やインターベンショナル手技に対する需要の高まりは、業界の投資家に有利な成長機会を提供しています。さらに、病院や手術センターにおける高度な手術機器に対する需要の高まりは、市場にプラスの影響を与えています。さらに、冠動脈造影やその他のインターベンショナル手技におけるバスキュラーアクセス用の大腿骨モードに対する需要が世界中で増加しています。これは、縫合や傷跡を避けるための非侵襲的処置に対する需要の高まりと相まって、市場にプラスの影響を与えています。これとは別に、外科手術中の患者の効果的な出血管理に対する医師の関心の高まりが、市場の成長を強化しています。さらに、この業界で事業を展開する主要メーカーは、大口径血管閉鎖装置の製造に注力しています。これに伴い、主要な市場参入企業による革新的なデバイスの登録数が増加しており、市場の成長を後押ししています。さらに、最小限の侵襲、高い患者予後、早期歩行、処置中の快適性など、VCDの利点に関する大衆の意識の高まりが、市場の成長を後押ししています。
The global vascular closure devices market size reached US$ 1.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5.1% during 2024-2032. The burgeoning healthcare industry, increasing prevalence of cardiovascular diseases, and the rising demand for effective blood loss management in patients represent some of the key factors driving the market.
Vascular closure devices (VCDs) are used in hospitals, clinics, and specialty and ambulatory surgery centers across the globe to immediately seal the small puncture made in an artery after an angiogram. These devices are widely utilized among patients undergoing catheterization via the femoral route as compared to traditional mechanical compression. They assist in reducing the risk of immediate bleeding from the groin puncture site. Besides this, they also aid in setting a large body habitus and anticoagulation and antiplatelet therapies. As they offer various benefits, such as reducing the time to hemostasis, facilitating patient mobilization, lowering patient discomfort associated with prolonged bed rest, decreasing hospital stays, and preventing femoral artery complications, the demand for VCDs is increasing worldwide.
At present, there is a rise in the prevalence of cardiovascular diseases (CVDs), such as stroke and coronary heart, peripheral arterial, and aortic diseases, across the globe. This, along with the burgeoning healthcare industry, represents one of the key factors supporting the growth of the market. Besides this, the escalating demand for catheterization and interventional procedures for diagnosing and treating CVDs is offering lucrative growth opportunities to industry investors. In addition, the growing demand for advanced surgical equipment in hospitals and surgical centers is positively influencing the market. Moreover, there is an increase in the demand for femoral mode for vascular access during coronary angiography and other interventional procedures around the world. This, coupled with the growing demand for non-invasive procedures to avoid stitches and scarring, is positively influencing the market. Apart from this, the rising focus of doctors on effective blood loss management in patients during surgical procedures is strengthening the growth of the market. Additionally, key manufacturers operating in the industry are focusing on manufacturing large-bore vascular closure devices. In line with this, the increasing number of registrations for innovative devices by key market players is propelling the growth of the market. Furthermore, the rising awareness among the masses about the benefits of VCDs, such as enabling minimal invasions, high patient outcomes, early ambulation, and comfort during procedures, is bolstering the growth of the market.
IMARC Group provides an analysis of the key trends in each segment of the global vascular closure devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, access, procedure, and end-user.
Passive Approximators
Collagen Plugs
Sealant or Gel-Based Devices
Compression-Assist Devices
Active Approximators
Suture-Based Devices
Clip-Based Devices
External Hemostatic Devices
The report has provided a detailed breakup and analysis of the vascular closure devices market based on the product. This includes passive approximators (collagen plugs, sealant or gel-based devices, and compression-assist devices), active approximators (suture-based devices and clip-based devices) and external hemostatic devices. According to the report, passive approximators represented the largest segment.
Femoral Access
Radial Access
A detailed breakup and analysis of the vascular closure devices market based on access has also been provided in the report. This includes femoral and radial access. According to the report, femoral access accounted for the largest market share.
Interventional Cardiology
Interventional Radiology/Vascular Surgery
A detailed breakup and analysis of the vascular closure devices market based on procedure has also been provided in the report. This includes the interventional cardiology and interventional radiology/vascular surgery. According to the report, interventional cardiology accounted for the largest market share.
Hospitals
Ambulatory Surgical Centers
Others
A detailed breakup and analysis of the vascular closure devices market based on end-user has also been provided in the report. This includes hospitals, ambulatory surgical centers, and others. According to the report, hospitals accounted for the largest market share.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and the Middle East and Africa. According to the report, North America was the largest market for vascular closure devices. Some of factors driving the North America vascular closure devices market included the growing prevalence of cardiovascular diseases, rising trend of one-day surgeries for vascular procedures, increasing clinical trials for vascular devices, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global vascular closure devices market. Detailed profiles of all major companies have also been provided. Some of the companies include Abbott Laboratories, Cardiva Medical Inc. (Haemonetics Corporation), Cordis Corporation (Cardinal Health Inc.), ENDOCOR GmbH & Co. KG, Merit Medical Systems Inc., Morris Innovative Inc., Teleflex Incorporated, Terumo Medical Corporation (Terumo Corporation), Transluminal Technologies LLC, Vasorum Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.